BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//MLSC - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.masslifesciences.com
X-WR-CALDESC:Events for MLSC
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200930T130000
DTEND;TZID=America/New_York:20200930T140000
DTSTAMP:20260404T120825
CREATED:20200924T143909Z
LAST-MODIFIED:20200924T143909Z
UID:12428-1601470800-1601474400@www.masslifesciences.com
SUMMARY:Reforming Philanthropy With a Racial Equity Lens
DESCRIPTION:With the advent of the COVID-19 crisis\, philanthropy stepped up and addressed the immediate funding needs of community organizations. But a question remains: Will philanthropy show up to address the long-standing issue of funding disparities for POC-led organizations and communities of color? \nCheryl L. Dorsey\, President of Echoing Green (1992 Echoing Green Fellow)\, and Orlando C. Watkins\, Vice President for Programs at the Boston Foundation (1994 Echoing Green Fellow)\, will discuss Cheryl’s research on racial bias in funding and the ways her organization has endeavored to mitigate the issue. Their conversation will also detail Orlando’s efforts to tackle the issue as a Black executive in philanthropy and how the philanthropic sector in Greater Boston can reform its funding practices with a racial equity lens.
URL:https://www.masslifesciences.com/event/reforming-philanthropy-with-a-racial-equity-lens/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201001T150000
DTEND;TZID=America/New_York:20201001T150000
DTSTAMP:20260404T120825
CREATED:20200928T133943Z
LAST-MODIFIED:20200928T133943Z
UID:12453-1601564400-1601564400@www.masslifesciences.com
SUMMARY:Access To Care Challenges And Innovation During Covid-19: An Oncology Perspective
DESCRIPTION:Join us for an informative discussion on how COVID-19 has affected patient access to diagnoses\, care\, and innovative therapies. We’ve assembled an expert panel that will explore these important issues from an oncology perspective.  Our forum – moderated by Robert K. Coughlin\, President & CEO of MassBio – will feature the following speakers: \n\nDr. Meghan Mooradian\, MD\, Clinical Oncologist\, Medical Oncology\, Massachusetts General Hospital\nKirsten Sloan\, Managing Director\, Policy\, American Cancer Society’s Cancer Action Network (ACS CAN)\nMichelle Carrillo\, Director\, Advocacy Relations-Oncology\, Amgen\n\nThe COVID-19 pandemic has had a profound\, direct impact on Massachusetts\, with over 121\,000 total cases-to-date. However\, as response and recovery continue\, the ripple effects reveal a much broader public health impact. Our health care system has been shaken to its core\, perhaps none more than the area of cancer care. \nAn American Cancer Society Cancer Action Network (ACS CAN) survey of cancer patients and survivors focused on COVID-19 effects uncovered that of those in active treatment\, 79% reported delays to their health care. What does the patient’s path to diagnosis and treatment look like? Has cancer care adapted to meet these challenges? How is Massachusetts uniquely positioned to meet the moment? Our panel of experts will address these questions and more from their patient\, oncologist\, and innovator perspectives.
URL:https://www.masslifesciences.com/event/access-to-care-challenges-and-innovation-during-covid-19-an-oncology-perspective/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201001T180000
DTEND;TZID=America/New_York:20201001T184000
DTSTAMP:20260404T120825
CREATED:20200917T132653Z
LAST-MODIFIED:20200917T132653Z
UID:12401-1601575200-1601577600@www.masslifesciences.com
SUMMARY:2020 Virtual Catalyst Awards - Science Club for Girls
DESCRIPTION:Join Science Club for Girls as we celebrate 25 years of empowering diverse girls and women in STEM—in Boston\, Cambridge\, Somerville\, and beyond—at our first-ever VIRTUAL Catalyst Awards! \nScience Club for Girls – 2020 Virtual Catalyst Awards\nThursday\, October 1\, 2020\n6:00 – 6:40 P.M. \nSee our in-person and virtual clubs in action\, hear from club participants and mentors\, and be inspired by this vibrant community of women and girls—who are paving the way for a more diverse\, inclusive world of STEM. We can’t wait to celebrate with you! \nRegister: https://tinyurl.com/virtualcatalyst2020 \nWe are thrilled to honor Catalyst Awards recipients Kaelyn Brown and Ashley Cooper—both Harvard College Neuroscience students—and Silver Anniversary Awards recipients\, Cambridge STEAM Initiative\, Geeta Pradhan of the Cambridge Community Foundation\, and the Women’s Foundation of Boston\, for their leadership in advancing opportunities for women and girls. \nKaelyn shares\, “[Science Club] gave me the opportunity to see that anything is possible\, and as a Black woman\, and a Black woman in STEM more specifically\, that’s really important.” Ashley\, who got involved her freshman year\, now mentors second graders\, many of whom began in Kindergarten. “I was really able to see that it shaped the formative ideas they had—that they do deserve to be in science and can understand the ideas being taught.” \nAll tickets and sponsorships purchased for the original in-person event are valid for the virtual event. Registration is free; we appreciate your donation!
URL:https://www.masslifesciences.com/event/2020-virtual-catalyst-awards-science-club-for-girls/
LOCATION:Online\, online
ORGANIZER;CN="Science Club for Girls":MAILTO:scfg@scienceclubforgirls.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201005
DTEND;VALUE=DATE:20201107
DTSTAMP:20260404T120825
CREATED:20200324T155103Z
LAST-MODIFIED:20200617T131742Z
UID:11404-1601856000-1604707199@www.masslifesciences.com
SUMMARY:Industrial Bioprocessing Course (Virtual)
DESCRIPTION:Hosted by the Biomanufacturing Innovation Institute (BII) and UMass Lowell \nWe invite you to join our Industrial Bioprocessing Course. We are planning a 5-day professional short course delivered virtually over 5 weeks from October 5th – November 6th. The course will be taught by industry professionals from BMS\, Pfizer\, MilliporeSigma\, and UMass experts. \nCourse Outline\nThe trainees will learn key principles and concepts of industrial bioprocessing of protein\, cell and gene therapies. The course covers recent technologies and practices of upstream\, downstream and analytical bioprocessing technologies. In addition\, FDA initiatives of PAT (Process Analytical Technology)\, Quality by Design\, and Emerging Technology will be covered. The course consists of 7 modules. \nCourse Modules\nModule 1\, Upstream Bioprocessing\nModule 2\, Downstream Bioprocessing\nModule 3\, Analytical Technology in Bioprocessing\nModule 4\, Cell Therapy & Bioprocessing\nModule 5\, Gene Therapy & Bioprocessing\nModule 6\, Regulatory\, QbD\, and PAT in Bioprocessing\nModule 7\, Big data Analytics for Biopharmaceutical \nWho can benefit from this professional course\nIndividuals that are involved in manufacturing\, product and process development\, regulatory\, QA/QC and of biotech therapeutics. Attendees from academia and regulatory agencies may also benefit depending on their areas of interest and level of experience. \nRegistration\nPlease head over to BlueSnap to complete your registration. For any question about the registration\, please contact us at bpqc@uml.edu. Registration deadline is September 1st\, 2020. \nContact Information\nFor any question\, please contact bpqc@uml.edu
URL:https://www.masslifesciences.com/event/industrial-bioprocessing-course/
LOCATION:UMass Lowell\, Lowell\, MA\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201005T090000
DTEND;TZID=America/New_York:20201009T113000
DTSTAMP:20260404T120825
CREATED:20200825T133116Z
LAST-MODIFIED:20200825T133116Z
UID:12230-1601888400-1602243000@www.masslifesciences.com
SUMMARY:Science Of Biotech 101 (October)
DESCRIPTION:This online course is designed for the non-scientists as a survey of the basic biological processes that are foundational to the Biopharma and life sciences industry. You will apply your new understanding of basic cell and molecular biology to the work of most life sciences companies that research and develop therapies and products that improve lives\, enhance agriculture\, and decrease the dependence on fossil fuels. \nSession 1: \nIntroductions\nIndustry Overview\nThe Raw Materials of Biotechnology: Protein and Cells\nIndustry Applications: The Raw Materials of Biotechnology: DNA\nSession 2: \nMolecular Biology: From DNA to Protein\nGenetics: Chromosomes\, Genes and Genomes\nIndustry Applications\nSession 3: \nGenetic Engineering\nThe Immune System\nIndustry Applications: Mitigating Disease\nCourse Schedule:\nMonday\, October 5th\, 2020 9:00-11:30 AM\nWednesday\, October 7th\, 2020 9:00-11:30 AM\nFriday\, October 9th\, 2020 9:00-11:30 AM
URL:https://www.masslifesciences.com/event/science-of-biotech-101-october/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201005T120000
DTEND;TZID=America/New_York:20201030T170000
DTSTAMP:20260404T120825
CREATED:20200930T134740Z
LAST-MODIFIED:20200930T134740Z
UID:12467-1601899200-1604077200@www.masslifesciences.com
SUMMARY:ISPE Boston Fall Educational Summit
DESCRIPTION:A month-long virtual conference featuring four tracks on industry topics\, networking opportunities\, and education throughout October! \nPROGRAM SUMMARY: \nThis event will offer the educational sessions\, normally presented in-person at the Annual Product Show\, in a virtual format. The Chapter’s Product Show committee and Educational Programs committee have been hard at work re-formulating these sessions for the virtual education space and are excited to bring you a new way to learn about industry topics and connect with colleagues both new and old. Registrants receive access to the full conference including every educational track. We’ll also be bringing you special virtual sessions from the Women In Pharma (WIP) Committee\, the Young Professionals Committee\, and the Professional Development Committee\, all included with your registration! \nEDUCATIONAL TRACKS:\nWEEK 1 / TRACK 1: Risk Management\nWEEK 2 / TRACK 2: ATMP\nWEEK 3 / TRACK 3: Facilities of the Future\nWEEK 4 / TRACK 4: Pharma 4.0
URL:https://www.masslifesciences.com/event/ispe-boston-fall-educational-summit/2020-10-05/
LOCATION:Online\, online
ORGANIZER;CN="ISPE Boston Area Chapter":MAILTO:office@ispeboston.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201006
DTEND;VALUE=DATE:20201009
DTSTAMP:20260404T120825
CREATED:20200924T143455Z
LAST-MODIFIED:20200924T143455Z
UID:12418-1601942400-1602201599@www.masslifesciences.com
SUMMARY:Immuno-Oncology Virtual Summit
DESCRIPTION:Over the past 8 years\, CHI’s Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research\, providing comprehensive and in-depth coverage across all modalities and stages in the pipeline. Every year\, we assemble an international mix of thought leaders and decision makers from industry and academia to bring you the latest developments in immuno-oncology\, while providing access to a comprehensive 3-day program and extensive networking opportunities. \nhttps://www.immuno-oncologysummit.com/
URL:https://www.masslifesciences.com/event/immuno-oncology-virtual-summit/
LOCATION:Online\, online
ORGANIZER;CN="Cambridge Innovation Institute":MAILTO:chi@healthtech.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201006T080000
DTEND;TZID=America/New_York:20201006T090000
DTSTAMP:20260404T120825
CREATED:20200825T204102Z
LAST-MODIFIED:20200825T204142Z
UID:12261-1601971200-1601974800@www.masslifesciences.com
SUMMARY:Life Science Cares Impact Breakfast: REIMAGINED!
DESCRIPTION:Life Science Cares is calling on life science\, biotech\, and medtech companies to take action against poverty during the organization’s annual Impact Breakfast fundraiser. \nThe 2020 event\, set for Tuesday\, Oct. 6\, from 8 to 9 a.m.\, is a virtual celebration raising critical dollars for Life Science Care’s end-of-year grant making to a network of nonprofits providing basic human services\, education and economic sustainability programs. Governor Deval Patrick\, the event’s keynote speaker\, will share his thoughts on the community’s collective responsibility to uphold the ideals of equity and access to opportunity for everyone\, especially people of color. Sarah MacDonald\, Executive Director of Life Science Cares\, will update attendees on the organization’s COVID-19 response and vision for equity. Since its founding in 2016\, Life Science Cares\, a platform for members of the life sciences industry to give back while also giving nonprofits the funds and volunteer power necessary to grow and innovate\, has worked with more than 350 companies to distribute more than $3.5 million in grants to 42 community organizations. In addition\, Life Science Cares has directed more than 12\,000 hours of community service from volunteers from the sector. \nNew this year\, companies may participate in the Life Science Cares Corporate Fundraising Challenge\, a friendly competition in which companies rally employees to engage in peer-to-peer fundraising campaigns to raise money to support the organization’s 27 nonprofit partners. Challenge Awards will be presented during the live virtual event\, which is open to professionals working across all industries. \nSponsorship of the event is available by contact Christine Casalini at christine@lifesciencecares.org. Individual tickets are $300 and must be purchased in advance.
URL:https://www.masslifesciences.com/event/life-science-cares-impact-breakfast-reimagined/
LOCATION:Online\, online
ORGANIZER;CN="Life Science Cares":MAILTO:info@lifesciencecares.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201007T120000
DTEND;TZID=America/New_York:20201007T140000
DTSTAMP:20260404T120825
CREATED:20201002T175838Z
LAST-MODIFIED:20201002T180242Z
UID:12482-1602072000-1602079200@www.masslifesciences.com
SUMMARY:Leveraging Government/Incubator Partnerships to Advance Your Life Sciences
DESCRIPTION:Government entities tasked with safeguarding the nation’s health security recognize life sciences incubators as abundant sources of new innovations that can potentially save lives. Join us and learn how to tap into these opportunities and accelerate your innovation. \nRepresentatives from BARDA\, BARDA DRIVe\, Johnson & Johnson Innovation | JLABS\, and the Massachusetts Medical Device Development Center (M2D2) will introduce you to the collaborations they’ve formed to help advance innovations tackling our biggest health security threats. \nYou’ll learn from BARDA and BARDA DRIVe about their missions\, areas of interests\, and opportunities they provide to help further innovation. \nYou’ll also hear from JLABS and M2D2\, two active incubator programs that have collaborated both together\, and independently with BARDA to serve as pipeline builders and resource centers. Not only do these centers compliment and expand on BARDA’s mission but they can work with you to fill in the advancement gaps needed to position your innovation on the path to success. \nJoin us and learn about the added-value government/incubator collaborations can bring to the table to help advance the opportunity of success for life science innovators. \nAgenda: \n• 12:00pm – 12:05pm: Opening Remarks & Intros \n• 12:05pm – 12:20pm: BARDA Presentation \n• 12:20pm – 12:35pm: BARDA DRIVe Presentation \n• 12:35pm – 12:45pm: BARDA Q&A \n• 12:45pm – 1:05pm: JLABS Presentation w/ Q&A \n• 1:05pm – 1:25pm: M2D2 Presentation w/ Q&A \n• 1:25pm – 1:55pm: Company Spotlights \n• 1:55pm – 2:00pm: Closing Remarks \nSpeakers:\nSandeep Patel – Director of BARDA Division of Research\, Innovation\, and Ventures (DRIVe) \nStephen Pitt – Head of JLABS @ US North East \nSteve Tello – Vice Provost for Graduate & Professional Studies \nCompany Spotlights:\nAdvanced Silicon Group: Marcie Black – CEO & Co-Founder \nPersephone Biosciences: Stephanie Culler – CEO & Co-Founder \nVersatope Therapeutics: Christopher Locher – CEO & Co-Founder \nCurie Co: Erika M. Milczek – CEO & Founder
URL:https://www.masslifesciences.com/event/leveraging-government-incubator-partnerships-to-advance-your-life-sciences/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201007T183000
DTEND;TZID=America/New_York:20201007T200000
DTSTAMP:20260404T120825
CREATED:20200930T134623Z
LAST-MODIFIED:20201002T184442Z
UID:12477-1602095400-1602100800@www.masslifesciences.com
SUMMARY:Women Accelerators: Podcast Party
DESCRIPTION:Join us for the inaugural Podcast Party event with Women Accelerators! \nThe October happy hour event will be like a book club\, but with podcasts. Listen to the list of podcast episodes around a central theme and reflect on the discussion prompts. \nOn the day of the event\, we will come together to learn and discuss as a group! \nCheck out the Eventbrite link for podcast episodes and discussion topics!
URL:https://www.masslifesciences.com/event/podcast-party/
LOCATION:Online\, online
ORGANIZER;CN="Women Accelorators":MAILTO:info@womenaccelerators.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201008T090000
DTEND;TZID=America/New_York:20201008T120000
DTSTAMP:20260404T120825
CREATED:20200904T174526Z
LAST-MODIFIED:20200904T174611Z
UID:12338-1602147600-1602158400@www.masslifesciences.com
SUMMARY:M2D2 International MedTech Forum 2020
DESCRIPTION:Discover breakthrough life sciences innovation straight out of India.  See six finalists pitch their ideas to a panel of leading investors. \nLife sciences innovation knows no borders—and the first M2D2 International MedTech Forum\, sponsored by the Deshpande Foundation\, will amplify six groundbreaking and life-saving ideas from India-based researchers. Tickets are free\, so please join us on October 8 for this virtual event. \nThe pandemic halted Deshpande Foundation’s plans to bring more Finalist teams to Massachusetts for the 2020 Challenge. So we’ve created a virtual forum for them to make their pitches. Join us to see their eye-opening ideas! \nThese six teams were chosen from among the 250 entries we received this winter for the 2020 $200K Challenge. They represent incubators including Indian Institute of Technology Madras/HTIC Chennai; NCL Innovation Park\, Pune\, and Indian Institute of Science\, Bengaluru\, as well as a private\, Bengaluru-based firm. \nChemBio—Plasmonic fiberoptic absorbance biosensor (P-FAB) technique \nCygenica—Oncology targeted delivery \nElchem—Electro-Chemo Therapy (ECT) treatment for tumor cells \nFast Sense—Portable diagnostic kits for complex diseases \nMimyk—AR/VR and robotics for surgical training \nNesa—Procedure to treat symptomatic uterine fibroids
URL:https://www.masslifesciences.com/event/m2d2-international-medtech-forum-2020/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201012
DTEND;VALUE=DATE:20201015
DTSTAMP:20260404T120825
CREATED:20200320T155612Z
LAST-MODIFIED:20200909T135454Z
UID:11407-1602460800-1602719999@www.masslifesciences.com
SUMMARY:Bioprocess Data Analytics and Machine Learning (Virtual)
DESCRIPTION:Lead Instructor(s)\nRichard D. Braatz\nBrian Anthony\nSeongkyu Yoon \nRegistration Deadline\nSeptember 1st\, 2020 \nCourse Fee\n$3\,500 \nCEUs\n2.0 \nDescription\nTHIS COURSE MAY BE TAKEN INDIVIDUALLY OR AS PART OF THE PROFESSIONAL CERTIFICATE PROGRAM IN MACHINE LEARNING & ARTIFICIAL INTELLIGENCE OR THE PROFESSIONAL CERTIFICATE PROGRAM IN BIOTECHNOLOGY & LIFE SCIENCES. \nBiotherapeutics has improved the lives of millions of patients around the world. In the past few years\, major advances in biomanufacturing analytics\, analytical technology\, and machine learning have deepened understanding of process operations and product quality in this important arena. \nOrganizations on the leading edge of bioprocess data analytics have already seen dramatic improvements in pharmaceutical batch optimization\, manufacturing scalability\, and regulatory efficiency. \nTo help you take advantage of these revolutionary developments—and drive breakthroughs of your own—MIT Professional Education is pleased to introduce Bioprocess Data Analytics and Machine Learning. In this intensive\, three-day course\, you’ll gain: \nA greater understanding of how bioprocess data analytics can be applied to develop and improve biotherapeutic manufacturing \nInsight into important advances in data analytics\, machine learning methods\, and software that provide new ways to build models\, diagnose problems\, and make informed decisions\nAn introduction to new sensor technologies\, including spectral imaging and real-time color video\, and the major classes of data analytics and machine learning methods used in bioprocess operations \nTools to systematically interrogate the data to ascertain specific characteristics needed to select among the best-in-class data analytics methods \nWith the guidance of academic and industry experts\, you’ll discover transformative ways to apply data analytics—and avoid the most common pitfalls that arise when analyzing bioprocess data. By the end of the course\, you’ll have an understanding of the best practices needed to translate biopharmaceutical manufacturing data into reliable models and better decisions. Simply put\, you’ll be able to select the right methods\, improve accuracy and effectiveness\, and save time and money. \nParticipant Takeaways\nApply new sensor technologies relevant to biopharmaceutical manufacturing processes\, such as spectral imaging and real-time color video\nUnderstand major classes of data analytics and machine learning methods relevant to bioprocess operations\nSystematically interrogate bioprocess data to ascertain characteristics (such as nonlinearity\, multicollinearity\, and dynamics)\nSelect among the best-in-class data analytics methods based on the objective and data characteristics\nSummarize ways to combine data-driven models with mechanistic understanding\nAvoid common pitfalls when analyzing bioprocess data \nWho Should Attend\nBioprocess Data Analytics and Machine Learning is designed for scientists and engineers in the biopharma industry who want to take their skills—and their careers—to the next level. In particular\, this course is well suited to individuals with job titles such as Data Scientist\, Senior Research Scientist\, and Bioprocess Engineer. Additionally\, workshop participants should have some experience with analyzing experimental data. \nRequirements\nParticipants should have some experience in data analytics and bioprocesses. In addition\, participants must be professionals with experience working in the pharmaceutical or biopharmaceutical industry.\nProgram Outline \nClasses will run on the following schedule:\nDay One: 9:00am – 7:00pm\nDay Two: 9:00am – 6:00pm\nDay Three: 9:00am – 6:30pm \nDAY ONE\n9 to 10:30am – Braatz/Anthony\nIntroduction to bioprocess data analytics: opportunities\, types of data analytics problems; supervised\, unsupervised\, and partially supervised learning; data visualization (software tools using data from bioprocess time series\, Raman spectroscopy\, spectral imaging\, LC-MS)\nReadings/Assignments: Lecture notes\n10:30 to 11am – Coffee and networking\n11am to 12:30pm – Braatz\nRegression: least squares\, response surface methodology\, ridge regression\, lasso\, elastic net\, cross-validation\, residual analysis\, outlier detection\, uncertainty quantification\, optimal experimental design\, feature engineering\, nonlinearities\, systematic method selection\, monoclonal antibody manufacturing industrial case study\nReadings/Assignments: Lecture notes\n12:30 to 1:30pm – Lunch and networking\n1:30 to 2:30pm – Braatz\nTour of biopharmaceutical manufacturing labs at MIT\, which includes fully automated and instrumented end-to-end continuous CHO-based monoclonal antibody production\nReadings/Assignments: Lecture notes\n2:30 to 3:30pm – Braatz\nTips and traps: correlation vs. causation\, inferences drawn from matching statistics\, effects of feedback loops\, selection among too many models\, studying features for biological/ chemical/physical reasonableness\, Google Flu Trends\nReadings/Assignments: Lecture notes\n3:30 to 5pm – Anthony/Braatz\nHands-on activities in visualizing and analyzing real biopharmaceutical process datasets\nReadings/Assignments: Students use their own laptops\n5 to 7pm – Course reception/networking \nDAY TWO\n9 to 10:30am – Yoon/Anthony\nTime series analysis: low-\, high-\, and band-pass filters; oscillatory data; Fourier transforms; ARMA; ARMAX; noise; AD convertors; sampling; aliasing; statistical process control (aka control charts)\, UV absorption for protein concentration measurement case study\nReadings/Assignments: Lecture notes\n10:30 to 11am – Coffee and networking\n11am to 12:30pm – Yoon\nLatent variable methods I: PCA\, multivariable statistical process control\, spectral sensor calibration\, PCR\, PLS\, spectral data artifacts\, Raman spectroscopy case study\nReadings/Assignments: Lecture notes\n12:30 to 1:30pm – Lunch and networking\n1:30 to 3pm – Yoon\nLatent variable methods II: CCA\, FDA\, missing data\, sparse models\, Raman and near-infrared case studies\nReadings/Assignments: Lecture notes\n3 to 3:30pm – Coffee and networking\n3:30 to 4:30pm – Yoon/Braatz/Anthony\nHands-on activities in visualizing and analyzing real biopharmaceutical process datasets\nReadings/Assignments: Students use their own laptops\n4:30 to 5:30pm – Yoon/Braatz/Anthony\nOpen discussions with the instructors\n5:30 to 6pm – Coffee and networking \nDAY THREE\n9 to 10:30am – Anthony/Braatz\nBig data analytics: real-time video\, thermal imaging\, tensor data\, hyperspectral imaging\, LC-MS\, multiway methods\, multilinear subspace learning\, lyophilization case studies\nReadings/Assignments: Lecture notes\n10:30 to 11am – Coffee and networking\n11am to 12:30pm – Anthony\nNonlinear analytics: support vector machines; random forests; comparisons to FDA and k-nearest neighbor classification; feature engineering revisited; kernel methods; hybrid models; autoassociative and recursive neural networks\nReadings/Assignments: Lecture notes\n12:30 to 2:30pm – Course lunch and networking\n2:30 to 4 pm – Anthony\nWhat can bioprocess analytics learn from other industries?\nReadings/Assignments: Lecture notes\n4 to 4:30pm – Coffee and networking\n4:30 to 5:30pm – Anthony/ Braatz\nHands-on activities in visualizing and analyzing real biopharmaceutical process datasets\nReadings/Assignments: Students use their own laptops\n5:30 to 6:30 – Anthony/ Braatz\nClosing reception \nContact Information\nFor any question\, please contact bpqc@uml.edu
URL:https://www.masslifesciences.com/event/bioprocess-data-analytics-and-machine-learning/
LOCATION:Online\, online
ORGANIZER;CN="MIT":MAILTO:lindsayk@mit.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201013T130000
DTEND;TZID=America/New_York:20201013T140000
DTSTAMP:20260404T120825
CREATED:20201013T132238Z
LAST-MODIFIED:20201013T132238Z
UID:12527-1602594000-1602597600@www.masslifesciences.com
SUMMARY:The Covid-19 pandemic and the race for vaccines
DESCRIPTION:Every week\, STAT Plus subscribers get access to exclusive conversations with biotech\, pharma and health tech leaders. For this month only\, thanks to Allscripts\, we’re inviting all STAT readers to join in on these conversations. See what we have scheduled\, and register below — and\, if you missed them\, be sure to view past conversations in our archive. \n\nHelen Branswell\, senior writer\, infectious disease\, STAT\nRick Berke\, co-founder & executive editor\, STAT (moderator)\nSponsor Introduction by Rebecca Whaley\, vice president of marketing\, AllScripts
URL:https://www.masslifesciences.com/event/the-covid-19-pandemic-and-the-race-for-vaccines/
LOCATION:Online\, online
ORGANIZER;CN="STAT":MAILTO:info@statnews.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201014
DTEND;VALUE=DATE:20201015
DTSTAMP:20260404T120825
CREATED:20200928T180618Z
LAST-MODIFIED:20200930T133103Z
UID:12460-1602633600-1602719999@www.masslifesciences.com
SUMMARY:The Connors Center IGNITE Awards
DESCRIPTION:The goal of the IGNITE Awards program is to advance understanding of female-specific and sex-differentiated effects in novel therapeutics (drugs\, devices\, and digital diagnostics and therapeutics) for diseases that affect women exclusively\, predominantly\, or differentially. IGNITE investigations are important components of the Connors Center’s First.In.Women Precision Medicine Platform. This RFP is open to investigators with a primary appointment at Brigham and Women’s Hospital. \nAmount: $50\,000\nLetter of Intent Deadline: October 14\, 2020 — 12pm\nApplication Deadline (by invitation only): December 4\, 2020 — 12pm
URL:https://www.masslifesciences.com/event/the-connors-center-ignite-award/
LOCATION:Online\, online
ORGANIZER;CN="Connors Center":MAILTO:meet@bc.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201014T100000
DTEND;TZID=America/New_York:20201014T110000
DTSTAMP:20260404T120825
CREATED:20201013T131937Z
LAST-MODIFIED:20201013T131937Z
UID:12524-1602669600-1602673200@www.masslifesciences.com
SUMMARY:Doing Business in a Pandemic: Resources & Guidance for Small Businesses & Nonprofits
DESCRIPTION:ABL and BECMA invite business and nonprofit leaders for a free panel discussion that will highlight resources and guidance for small organizations as they navigate the impact of the economic and health crisis caused by COVID-19. \nModerated by Segun Idowu\, Executive Director of the Black Economic Council of Massachusetts (BECMA)\, panelists will share the local\, state\, and federal resources and economic relief available now\, as well as discuss the systemic policy changes needed to better support and sustain small businesses and employees through the recovery. Panelists will also answer questions from business leaders; speakers include: \n•Quincy Miller\, President\, Eastern Bank\n•Natalia Urtubey\, Director of Small Business\, City of Boston Mayor’s Office of Economic Development\n•Margaret Laforest\, Regional Director\, Massachusetts Office of Business Development \nABL is committed to offering free programs and resources to the business community as we navigate the COVID-19 crisis together. This program is hosted in partnership with BECMA. This series is made possible by the support of Blue Cross Blue Shield of Massachusetts. \nThe Alliance for Business Leadership (ABL) is a coalition of progressive CEOs\, entrepreneurs\, investors\, and business leaders at all levels who believe that social responsibility and the sustainable growth of the Massachusetts economy go hand in hand.
URL:https://www.masslifesciences.com/event/doing-business-in-a-pandemic-resources-guidance-for-small-businesses-nonprofits/
LOCATION:Online\, online
ORGANIZER;CN="The Alliance for Business Leadership":MAILTO:info@alliancebl.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201014T130000
DTEND;TZID=America/New_York:20201014T140000
DTSTAMP:20260404T120825
CREATED:20201014T154314Z
LAST-MODIFIED:20201014T154430Z
UID:12519-1602680400-1602684000@www.masslifesciences.com
SUMMARY:Let's Talk About Webinar Clinical Inequities - How to Increase Diversity in Clinical Trials
DESCRIPTION:According to the CDC\, Native Americans\, African-Americans\, and Latinx people are three times more likely to contract COVID-19. And they are 4-5X more likely to be hospitalized due to it. Yet\, people of color are underrepresented in COVID-19 clinical trials. That’s a serious problem! \nIn 1993 the U.S. passed the NIH Revitalization Act\, establishing guidelines for the inclusion of women and minorities in clinical research. Not much has changed since 1993. There is a disparity between people of color and clinical trials. In this session\, our experts will weigh in on this systemic problem\, the advancements that will ensure more inclusivity\, and how start-ups can lead the change. \nSPEAKERS\nRose Blackburne\, MD\, MBA\, Executive Medical Director of Global Product Development\, PPD\nDr. Rose Blackburne joined PPD in 2015. As Global Head of the General Medicine portfolio\, which includes Women’s Health\, Nephrology\, Dermatology\, Urology\, she has strategic input and oversight for a portfolio of pharmaceutical and medical device product development opportunities across these areas. Dr. Blackburne is a globally recognized leader in product development and has been instrumental in numerous approvals for pharmaceuticals\, vaccines\, medical devices and diagnostic tests. Dr. Blackburne is passionate about improving health outcomes and health care delivery and has extensive expertise in Women’s Health and Minority Health Policy. \nRonke Dosunmu\, MD\, Pediatrician\, Founder of Foundation Pediatrics\nDr. Ronke Dosunmu is a board-certified pediatrician and is the founder of Foundation Pediatrics\, a 25-year-old private practice serving an inner-city area in Northern NJ. She has worked for many major pharmaceutical companies as well as consulted in the field of drug safety and pharmacovigilance. She is an experienced Principal investigator and knows first hand the difficulty with recruiting minorities into clinical trials. Dr. Dosunmu is passionate about reducing healthcare disparities\, especially in clinical research participation. \nR’Kes Starling\, RPh\, MBA\, President & Chief Executive Officer\, Reveles Clinical Services\nAs CEO and Founder of Reveles Clinical Services\, R’Kes has over 18 years providing high-touch pharmacy services\, clinical reach operations\, specialty drug distribution\, and clinical management to patients with rare and complex diseases such as Chronic Kidney disease\, Cancer\, Hemophilia and Cystic Fibrosis. Additionally\, R’Kes has consulted and worked collaboratively with over 30 biopharmaceutical companies on pre-launch to commercialization development\, launch strategies\, and patient access programs for new specialty pharmaceutical therapies. \nMODERATOR\nRachael Fones\, Director\, Government & Public Affairs at IQVIA\nRachael Fones facilitates IQVIA’s engagement in public policy discussions with elected officials\, regulatory bodies\, industry associations\, and patient and issue advocacy groups. With 14 years at IQVIA\, previously Quintiles\, she specializes in identifying policy opportunities and collaborations to advance the broader clinical research enterprise. Prior to joining Quintiles\, Fones served as a senior public relations and third-party advocacy consultant for Blue Cross and Blue Shield of Florida in Jacksonville\, Fla.\, and Executive Director of the Health Care Quality Alliance (HCQA) in Washington\, D.C.
URL:https://www.masslifesciences.com/event/lets-talk-about-webinar-clinical-inequities-how-to-increase-diversity-in-clinical-trials/
LOCATION:Online\, online
ORGANIZER;CN="LaunchBio":MAILTO:joan@launchbio.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201019T090000
DTEND;TZID=America/New_York:20201023T113000
DTSTAMP:20260404T120825
CREATED:20200825T133511Z
LAST-MODIFIED:20200825T133511Z
UID:12222-1603098000-1603452600@www.masslifesciences.com
SUMMARY:Business Of Biotech 101 (October)
DESCRIPTION:This MassBioEd online course explores the business considerations that drive company strategies. Participants are provided with an overview of how the industry works\, why it works the way it does\, and how the industry may change in the years ahead. For those considering careers in the biopharma space or transitioning from the science and technical aspects of the industry to the business side\, this course delivers a sound\, basic understanding of the “business of biotech”. Students will be provided foundational information about the BioPharma industry and regulation via instruction\, storytelling\, and breakout group discussions. Industry ethics will be discussed\, with emphasis on historical precedents. We will explore the decision-making process by touching on relevant topics such as market share\, phases of development\, patient population\, and safety profile. Guest speakers will be invited to represent specific considerations and to showcase their roles and experiences. We will embark upon a high-level overview of Research and Development\, including pre-clinical through market approval. \nCourse Schedule: \nMonday\, October 19th\, 2020 9:00 AM – 11:15 AM\nWednesday\, October 21st\, 2020 9:00 AM – 11:15 AM\nFriday\, October 23rd\, 2020 9:00 AM – 11:15 AM
URL:https://www.masslifesciences.com/event/business-of-biotech-101-october/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201020T100000
DTEND;TZID=America/New_York:20201021T153000
DTSTAMP:20260404T120825
CREATED:20200917T133427Z
LAST-MODIFIED:20200917T133427Z
UID:12373-1603188000-1603294200@www.masslifesciences.com
SUMMARY:2020 Global Conference on Regulatory Science
DESCRIPTION:Hosted by Harvard-MIT Center for Regulatory Science\, the 2020 Global Conference on Regulatory Science will convene academic scientists and physicians\, international regulators\, industry experts and patient groups to explore emerging topics at the intersection between regulatory science and therapeutic development. \nThe first in an annual series of conferences\, a key aim is to advance and sustain a dialogue between academic investigators active in the field and government and industry groups for whom the evaluation\, regulation and marketing of medical products is a central concern. The two-day conference will include plenary presentations\, panel discussions\, breakout sessions\, and a poster session. \n2020 Theme: Machine Learning and Data Science. The conference will cover diverse ways in which new computational approaches are integrating preclinical and clinical trial data\, real-world evidence\, information from electronic devices etc. to change drug development and medical care.
URL:https://www.masslifesciences.com/event/2020-global-conference-on-regulatory-science/
LOCATION:Online\, online
ORGANIZER;CN="Harvard-MIT Center for Regulatory Science":MAILTO:hits_regsci@harvard.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201020T120000
DTEND;TZID=America/New_York:20201020T123000
DTSTAMP:20260404T120825
CREATED:20200827T141052Z
LAST-MODIFIED:20200827T141052Z
UID:12280-1603195200-1603197000@www.masslifesciences.com
SUMMARY:A Technologist's Journey Through Medicine
DESCRIPTION:In this Harvard Medical School webinar\, Prem Ramaswami\, Head of Product at Sidewalk Labs\, an Alphabet company focused on increasing the sustainability and affordability of cities discusses when in the early days of COVID\, he worked closely with Boston Children’s Hospital and Harvard Health Map to bring together a group of tech company volunteers to launch CovidNearYou.org\, a crowd-sourced surveillance app. Previously\, Prem led Google Search’s efforts around Social Impact including Health\, Civics\, Education\, Crisis Response\, and Social Good. While he was at Google\, Prem helped develop and attended the first cohort of HMS’s Executive Education program for Google.
URL:https://www.masslifesciences.com/event/a-technologists-journey-through-medicine/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201020T130000
DTEND;TZID=America/New_York:20201022T150000
DTSTAMP:20260404T120825
CREATED:20200825T133429Z
LAST-MODIFIED:20200825T133429Z
UID:12225-1603198800-1603378800@www.masslifesciences.com
SUMMARY:Building Self-Awareness & Improving Personal Effectiveness
DESCRIPTION:This two-session\, interactive course helps participants build effective interpersonal skills and provides tools for objective and subjective self-evaluation – both critical to success in the biotech industry. Through a combination of discussion\, demonstration\, group exercises\, peer and coach feedback\, homework and substantial practice\, individuals will learn to identify their own communication strengths and will work on developing the areas that need improvement. \nTopics covered will\, in part\, be determined by participants who will be encouraged to bring their individual concerns to the training. In addition\, focus areas will include the following valuable topics: \nUnderstanding Listener Needs\nListening Actively\nDemonstrating Emotional Intelligence\nHandling Questions\nControlling Personal Bias\nAvoiding Emotional Hooks\nRecognizing 6 Parts of Human Behavior \nCourse Schedule: \nTuesday\, October 20th\, 2020\, 1:00 PM – 03:00 PM\nThursday\, October 22nd\, 2020\,1:00 PM – 03:00 PM
URL:https://www.masslifesciences.com/event/building-self-awareness-improving-personal-effectiveness/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201020T180000
DTEND;TZID=America/New_York:20201020T190000
DTSTAMP:20260404T120825
CREATED:20201019T215121Z
LAST-MODIFIED:20201019T215121Z
UID:12557-1603216800-1603220400@www.masslifesciences.com
SUMMARY:Advancing Your Career as a Woman in STEM
DESCRIPTION:Wondering how to advocate for yourself and propel your career? Come learn from our awesome female panelists who will share advice and tips on how to advance your career in biotech. Join MASS AWIS\, The Social Scientist and Central MA AWIS to learn how to advance your careers to become leaders in your companies!
URL:https://www.masslifesciences.com/event/advancing-your-career-as-a-woman-in-stem/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201021T140000
DTEND;TZID=America/New_York:20201021T144500
DTSTAMP:20260404T120825
CREATED:20201014T155932Z
LAST-MODIFIED:20201014T155932Z
UID:12548-1603288800-1603291500@www.masslifesciences.com
SUMMARY:Virtual Building Dedication Ceremony of the Astellas Institute for Regenerative Medicine (AIRM)
DESCRIPTION:Hear about the latest innovation in regenerative medicine as we introduce our state-of-the-art research and manufacturing regenerative medicine facility. \nOur virtual event will include remarks from \n\nThe Honorable Karyn Polito\, Lieutenant Governor of the Commonwealth of Massachusetts\nKenji Yasukawa\, President & CEO\, Astellas\nDr. Robert Langer\, David H. Koch Institute Professor at MIT\nDr. Robert Lanza\, Head of Astellas Global Regenerative Medicine\, Chief Scientific Officer\, Astellas Institute for Regenerative Medicine\nRobert Coughlin\, President & CEO\, Massachusetts Biotechnology Council\nThe AIRM Leadership Team\n\nA traditional Japanese sake ceremony will conclude the dedication.
URL:https://www.masslifesciences.com/event/virtual-building-dedication-ceremony-of-the-astellas-institute-for-regenerative-medicine-airm/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201022T130000
DTEND;TZID=America/New_York:20201022T140000
DTSTAMP:20260404T120825
CREATED:20200924T143042Z
LAST-MODIFIED:20200924T143042Z
UID:12423-1603371600-1603375200@www.masslifesciences.com
SUMMARY:Discover How to Design and Lead a Thriving Company as a Founder
DESCRIPTION:Culture is a way to align people with shared values to support each other to overcome challenges and achieve ambitious goals efficiently and meaningfully. As the saying goes\, “culture eats strategy for breakfast.” However\, designing and scaling a people and purposecentric culture can be hard\, especially for fast-growing companies. Your company’s culture impacts everything from your productivity\, engagement\, and customer loyalty\, to your speed of innovation\, retention of talent\, growth\, and\, of course\, profitability. By creating a thriving company built on cultural design\, futuristic leadership\, and customer-centric strategies\, companies can achieve sustainable long-term success. \nIn this session\, you will meet the award-winning entrepreneur with nearly two decades of experience working with founders and CEOs. Therese Gedda is often referred to as a “Master Teacher\,” “Founder Therapist\,” and “Yoda” by the over 1\,000 founders\, CEOs\, and executives she has been working with over the years. She is a recognized expert within company culture\, scaling companies\, and the high achiever mindset. Over the last few years\, she has been working with several Massachusetts-based BioTech\, MedTech\, and Life Science companies as an Executive Coach\, CEO advisor\, and cultural expert. \nIn the session\, we will uncover how to design a thriving company culture with an interdisciplinary team. As a founder\, you will also learn actionable leadership techniques that align with your desired culture. As an additional bonus\, since an intentionally well-designed culture helps you be even more of who you are\, you will also learn techniques for peaking your performance as a founder. \n“Therese is an extraordinary Founder/Executive Coach\, and working with her continues to have a significant impact on my career and life.” – Jan Schnorr\, Co-founder of C2Sense. \n“When I talk about Therese with fellow founders\, I often refer to her as a “founder therapist” – someone that can empathize and share the burden of your journey and help you navigate successfully. I’ve personally recommended her to many of my founder friends who have subsequently gone on to refer her to their friends – a testament to her continued impact.” – Sridhar Iyengar\, Founder & CEO at Elemental Machines.
URL:https://www.masslifesciences.com/event/discover-how-to-design-and-lead-a-thriving-company-as-a-founder/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201026T073000
DTEND;TZID=America/New_York:20201027T130000
DTSTAMP:20260404T120825
CREATED:20200416T181609Z
LAST-MODIFIED:20200416T181609Z
UID:11592-1603697400-1603803600@www.masslifesciences.com
SUMMARY:The AI Applications in Biopharma Summit
DESCRIPTION:The AI Applications in Biopharma Summit is a new kind of collaborate experience where the industry’s top science minds\, AI technology experts and strategy leaders share detailed use cases to improve patients lives. \nThe Summit is your chance to engage in deep coverage of AI in drug discovery\, clinical development and real-world evidence.
URL:https://www.masslifesciences.com/event/the-ai-applications-in-biopharma-summit/
LOCATION:Joseph B. Martin Conference Center at Harvard Medical School\, 77 Avenue Louis Pasteur\, Boston\, MA\, 02115\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201026T100000
DTEND;TZID=America/New_York:20201030T123000
DTSTAMP:20260404T120825
CREATED:20200825T133352Z
LAST-MODIFIED:20200825T133352Z
UID:12228-1603706400-1604061000@www.masslifesciences.com
SUMMARY:Presenting With Persuasion\, Clarity & Strength
DESCRIPTION:The ability to speak in a clear\, comfortable\, and confident manner is a key skill for all biotech industry professionals. Whether presenting internally to a small group of peers\, entire departments\, management\, or externally to clinicians\, patient advocates\, other medical professionals\, the press\, or investors\, telling your story effectively\, delivering meaningful messages\, being persuasive\, and speaking confidently in a variety of settings takes skill development and practice. The workshop will be interactive\, with practice\, role playing\, and exercises. Combining this approach with a comprehensive agenda ensures participants will gain important\, practical\, lifelong skills that they can put to immediate use. \nCourse Schedule: \nMonday\, October 26th\, 2020\, 10:00-12:30 PM\nTuesday\, October 28th\, 2020\, 10:00-12:30 PM\nThursday\, October 30th\, 2020\, 10:00-12:30 PM \nThe following topics will be covered in three 2.5 hour sessions virtually: \nOrganizing Content\nHandling Questions\nProjecting Confidence\nBeing Persuasive\nManaging Nervousness\nUsing Technical Visuals\nBuilding a Cohesive Story \nSession I \nIntroduction\nSharing communication challenges\nUnderstanding the Listener’s Needs\nUnderstanding the Communication Environment\nIdentifying Theme\nOrganizing Content\nBeing Persuasive \nSession II\nControlling Nervousness\nUsing Notes\nWorking with Visual Aids\nBest Practices for Presenting Virtually\nHandling Questions \nSession III\nPractice Strategies\nDelivering Presentation to Group for feedback and coaching
URL:https://www.masslifesciences.com/event/presenting-with-persuasion-clarity-strength/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201027T100000
DTEND;TZID=America/New_York:20201027T110000
DTSTAMP:20260404T120825
CREATED:20201002T201744Z
LAST-MODIFIED:20201014T183309Z
UID:12495-1603792800-1603796400@www.masslifesciences.com
SUMMARY:MLSC Seed Fund Information Session
DESCRIPTION:Join the MLSC Seed Fund team as they provide an informational overview of the program. The MLSC’s Seed Fund is providing up to $250\,000 in convertible notes for companies who have yet to raise their first priced round. The fund is focused on seeding companies with the intent to locate in 8 key communities\, which include: Amherst\, Beverly\, Lowell\, Mansfield\, North Adams\, Springfield\, Pittsfield\, and Worcester. Following the presentation will be an opportunity for Q&A. \nVisit the Seed Fund Program details page.
URL:https://www.masslifesciences.com/event/mlsc-seed-fund-information-session/
LOCATION:Online\, online
ORGANIZER;CN="Massachusetts Life Sciences Center":MAILTO:info@masslifesciences.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201027T120000
DTEND;TZID=America/New_York:20201027T130000
DTSTAMP:20260404T120825
CREATED:20201023T152604Z
LAST-MODIFIED:20201023T152604Z
UID:12611-1603800000-1603803600@www.masslifesciences.com
SUMMARY:Tap into The SBIR Center of Excellence
DESCRIPTION:UMass M2D2 and The UMass Lowell Research Institute’s NorthStar Campus have partnered together to bring you SBIR support! During this webinar you will learn more about the SBIR process\, the support we provide and all of the resources we have to help further the production of medical device and biotech innovation. \nHow can SBIR help your life sciences startup? \nSBIR is a highly competitive program that encourages domestic small businesses to engage in Federal Research/Research and Development (R/R&D) with the potential for commercialization. Through a competitive awards-based program\, SBIR enables small businesses to explore their technological potential and provide the incentive to profit from its commercialization. \nAbout the Northstar Campus \nWhen you choose UMass M2D2 and NorthStar you gain access to the state-of-the-art resources located at UMass Lowell and UMass Medical campuses\, as well as industry experts in science\, business development\, contracting and more! We meet 1:1 with companies to review their technology and help them locate applicable opportunities for government agencies including DOD\, NSF\, NIH\, DOE\, NASA\, NIST and BARDA. Offering support for Phase 1 and Phase 2 applicants\, we are your one stop shop for grant writing expertise. \nNot only do we house an SBIR Center of Excellence\, but we also offer a number of on-site resources to help you develop your technology. In addition to connections with industry partners\, we also provide wet/dry lab space\, office/meeting space\, business development support\, connectivity to UMass core labs/researchers and meetings/connections to subject matter experts (legal\, technical/science/engineering\, clinician review/clinical trials\, business\, fundraising\, regulatory) and more! The resources are endless\, register now to reserve your spot and learn more.
URL:https://www.masslifesciences.com/event/tap-into-the-sbir-center-of-excellence/
LOCATION:Online\, online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201027T180000
DTEND;TZID=America/New_York:20201027T193000
DTSTAMP:20260404T120825
CREATED:20201014T154639Z
LAST-MODIFIED:20201015T201554Z
UID:12500-1603821600-1603827000@www.masslifesciences.com
SUMMARY:Diversity in STEM Panel
DESCRIPTION:In our current political\, social\, cultural climate a resounding call for diversity and inclusion can be heard.  Join this FREE panel discussion to learn more about topics such as: \nDiversity in the biotech space\nDiversity and Bias in scholarly publishing\nCombating a lack of diversity in clinical trials\nPersonal experiences of a lack of diversity in STEM\nHow to support women and the next generation of STEM professionals\nHow to facilitate and create environments conducive for inclusion \nThe goal is for participants to leave the panel discussion with talking points and action steps to support diversity in STEM.
URL:https://www.masslifesciences.com/event/diversity-in-stem-panel/
LOCATION:Online\, online
ORGANIZER;CN="Women Accelorators":MAILTO:info@womenaccelerators.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201028T170000
DTEND;TZID=America/New_York:20201028T210000
DTSTAMP:20260404T120825
CREATED:20201014T154206Z
LAST-MODIFIED:20201014T160416Z
UID:12522-1603904400-1603918800@www.masslifesciences.com
SUMMARY:Virtual BioXchange Sponsored by Scaler Marketing
DESCRIPTION:Miss being able to network with colleagues in the life science industry? We have you covered with the best virtual networking experience through Grapevine Network’s platform. Connect with colleagues from all over the world. \nBioXchange has gone virtual to allow the best online opportunity to interact with individuals from throughout the life science industry. The event is being powered on Grapevine Network’s platform which provides an amazing experience that allows attendees the freedom to check in and out of different group discussions through an interactive chatroom environment. This platform provides the closest experience to an actual networking event since before the pandemic hit. \n***Event is expected to sell out and NOT ALL RVSPS ARE GUARANTEED ENTRY into the event due to the limited attendee capacity offered on the platform. \nInformation on this Month’s Sponsor: \nScaler Marketing \nTurn your dreams into realities and go where YOU want to go. \nYou know you have a unique mission in this world and that your company has its own unique value proposition. \nOur job is to make sure everyone else knows it too.
URL:https://www.masslifesciences.com/event/virtual-bioxchange-sponsored-by-scaler-marketing-2/
LOCATION:Online\, online
ORGANIZER;CN="BioXchange":MAILTO:bioxchange.boston@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201102T090000
DTEND;TZID=America/New_York:20201106T113000
DTSTAMP:20260404T120825
CREATED:20200825T135151Z
LAST-MODIFIED:20200825T135151Z
UID:12204-1604307600-1604662200@www.masslifesciences.com
SUMMARY:Transitioning To Leader\, For New Managers (November)
DESCRIPTION:Participants of this course will gain a clear understanding of the leader-manager they aim to be and the essential skills and strategies to help them get there. This interactive online course focuses on fundamentals for interviewing and hiring\, and strategies for how to develop employees and set them up for success. Other topics of discussion include approaches to effective communication and how to foster collaboration among teams\, both remotely and in-person. \nCourse Objectives: \nGain insight into the interdependence of leadership and management in your role and learn how to become an effective leader-manager.\nUnderstand how to lead behavioral-based interviews and achieve valuable outcomes in hiring.\nBecome confident in setting employees up for success and understand the key principles in managing performance and delivering feedback.\nDiscover how to create a collaborative agenda for remote and in-person meetings\nEnhance the impact of teamwork by reviewing the five qualities of effective remote collaboration\nIdentify specific actions you can take to build trust and psychological safety with direct reports and other key relationships.\nDevelop increased awareness of the trade-offs associating in various communication choices.\nLearn approaches to fostering collaboration across a group or team. \nCourse Schedule: \nMonday\, November 2nd\, 2020 9:00 AM – 11:15 AM\nWednesday\, November 4th\, 2020 9:00 AM – 11:15 AM\nFriday\, November 6th\, 2020 9:00 AM – 11:15 AM
URL:https://www.masslifesciences.com/event/transitioning-to-leader-for-new-managers-november/
LOCATION:Online\, online
END:VEVENT
END:VCALENDAR